We are international
Donate
TEXT SIZE   

Key Myeloma Questions for 2010: Latest Developments in Diagnosis, Prognosis, and Treatment
December 1, 2010
Orlando, Florida

ASH 2010 IMF Satellite Symposium

01.18.11   IMF Satellite Symposium: Key Myeloma Questions for 2010
Introduction
Brian G.M. Durie, MD
National Director, Hematologic Malignancies and Multiple Myeloma
Aptium Oncology, Inc.

01.18.11   IMF Satellite Symposium: Key Myeloma Questions for 2010
Diagnosis, Prognosis, and Risk Assessment in Multiple Myeloma
S. Vincent Rajkumar, MD
Mayo Clinic
Rochester, Minnesota

01.18.11   IMF Satellite Symposium: Key Myeloma Questions for 2010
Evolving Treatment Approaches in Transplantation-Eligible Myeloma Patients
Jesús San Miguel, MD
Hospital Clinico Universitario
Universidad de Salamanca
Salamanca, Spain

01.18.11   IMF Satellite Symposium: Key Myeloma Questions for 2010
Emerging Therapies for Transplantation-Ineligible Patients With Myeloma
Antonio Palumbo, MD
Ospedale Molinette
Torino, Italy

01.18.11   IMF Satellite Symposium: Key Myeloma Questions for 2010
Consolidation and Maintenance in Newly Diagnosed Symptomatic Multiple Myeloma
Philippe Moreau, MD
University Hospital
Nantes, France

01.18.11   IMF Satellite Symposium: Key Myeloma Questions for 2010
Novel Agents and Regimens for Relapsed and Refractory Multiple Myeloma
Robert Z. Orlowski, MD
MD Anderson Cancer Center
Houston, Texas, USA